Similar articles

• Treatment of hyperthyroidism in pregnancy and birth defects.

  Clementi M, Di Gianantonio E, Cassina M, Leoncini E, Botto LD, Mastroiacovo P; SAFE-Med Study Group. Clementi M, et al. J Clin Endocrinol Metab. 2010 Nov;95(11):E337-41. doi: 10.1210/jc.2010-0652. Epub 2010 Jul 28. J Clin Endocrinol Metab. 2010. PMID: 20668039
• Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study.

  Andersen SL, Olsen J, Wu CS, Laurberg P. Andersen SL, et al. J Clin Endocrinol Metab. 2013 Nov;98(11):4373-81. doi: 10.1210/jc.2013-2831. Epub 2013 Oct 22. J Clin Endocrinol Metab. 2013. PMID: 24151287
• Propylthiouracil versus methimazole during pregnancy: an evolving tale of difficult choices.

  Rivkees SA. Rivkees SA. J Clin Endocrinol Metab. 2013 Nov;98(11):4332-5. doi: 10.1210/jc.2013-3549. J Clin Endocrinol Metab. 2013. PMID: 24194618 No abstract available.
• [The use of antithyroid drugs should be reduced as much as possible in the first trimester].

  Andersen SL, Laurberg P. Andersen SL, et al. Ugeskr Laeger. 2014 Sep 22;176(39):V05140299. Ugeskr Laeger. 2014. PMID: 25294327 Review. Danish.
• Safety of antithyroid drugs in pregnancy: update and therapy implications.

  Francis T, Francis N, Lazarus JH, Okosieme OE. Francis T, et al. Expert Opin Drug Saf. 2020 May;19(5):565-576. doi: 10.1080/14740338.2020.1748007. Epub 2020 Apr 1. Expert Opin Drug Saf. 2020. PMID: 32223355 Review.